InChI=1S/C42H53NO15/c1-8-42(51)17-28(33-22(35(42)41(50)52-7)14-23-34(38(33)49)37(48)32-21(36(23)47)10-9-11-26(32)45)56-30-15-24(43(5)6)39(19(3)54-30)58-31-16-27(46)40(20(4)55-31)57-29-13-12-25(44)18(2)53-29/h9-11,14,18-20,24,27-31,35,39-40,45-46,49,51H,8,12-13,15-17H2,1-7H3/t18-,19-,20-,24-,27-,28-,29-,30-,31-,35-,39+,40+,42+/m0/s1 |
USZYSDMBJDPRIF-SVEJIMAYSA-N |
CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O[C@H]3C[C@H](O)[C@H](O[C@H]4CCC(=O)[C@H](C)O4)[C@H](C)O3)[C@H](C)O2)N(C)C)c2c(O)c3C(=O)c4c(O)cccc4C(=O)c3cc2[C@H]1C(=O)OC |
|
antimicrobial agent
A substance that kills or slows the growth of microorganisms, including bacteria, viruses, fungi and protozoans.
EC 5.99.1.3 [DNA topoisomerase (ATP-hydrolysing)] inhibitor
A topoisomerase inhibitor that inhibits DNA topoisomerase (ATP-hydrolysing), EC 5.99.1.3 (also known as topoisomerase II and as DNA gyrase), which catalyses ATP-dependent breakage of both strands of DNA, passage of the unbroken strands through the breaks, and rejoining of the broken strands.
apoptosis inducer
Any substance that induces the process of apoptosis (programmed cell death) in multi-celled organisms.
bacterial metabolite
Any prokaryotic metabolite produced during a metabolic reaction in bacteria.
metabolite
Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites.
(via anthracycline )
|
|
antineoplastic agent
A substance that inhibits or prevents the proliferation of neoplasms.
|
|
View more via ChEBI Ontology
methyl (1R,2R,4S)-2-ethyl-2,5,7-trihydroxy-6,11-dioxo-4-{[2,3,6-trideoxy-4-O-{2,6-dideoxy-4-O-[(2R,6S)-6-methyl-5-oxotetrahydro-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl}-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy}-1,2,3,4,6,11-hexahydrotetracene-1-carboxylate
|
aclarubicin
|
KEGG DRUG
|
aclarubicina
|
WHO MedNet
|
aclarubicine
|
ChemIDplus
|
aclarubicinum
|
ChemIDplus
|
80
|
DrugCentral
|
Aclarubicin
|
Wikipedia
|
C18638
|
KEGG COMPOUND
|
CPD-12960
|
MetaCyc
|
D02756
|
KEGG DRUG
|
G09914
|
KEGG GLYCAN
|
View more database links |
4901152
|
Reaxys Registry Number
|
Reaxys
|
57576-44-0
|
CAS Registry Number
|
KEGG COMPOUND
|
57576-44-0
|
CAS Registry Number
|
ChemIDplus
|
19626543
|
PubMed citation
|
Europe PMC
|
19744710
|
PubMed citation
|
Europe PMC
|
20047095
|
PubMed citation
|
Europe PMC
|
20399885
|
PubMed citation
|
Europe PMC
|
20855424
|
PubMed citation
|
Europe PMC
|
21130493
|
PubMed citation
|
Europe PMC
|
21939347
|
PubMed citation
|
Europe PMC
|
22077238
|
PubMed citation
|
Europe PMC
|
22082134
|
PubMed citation
|
Europe PMC
|
22374527
|
PubMed citation
|
Europe PMC
|
22493369
|
PubMed citation
|
Europe PMC
|
23418619
|
PubMed citation
|
Europe PMC
|
23432721
|
PubMed citation
|
Europe PMC
|
23533247
|
PubMed citation
|
Europe PMC
|
23537708
|
PubMed citation
|
Europe PMC
|
23595277
|
PubMed citation
|
Europe PMC
|
23602475
|
PubMed citation
|
Europe PMC
|
23613979
|
PubMed citation
|
Europe PMC
|
23616245
|
PubMed citation
|
Europe PMC
|
23664707
|
PubMed citation
|
Europe PMC
|
|